PYEROB: Robot-Assisted Pyeloplasty in Young Children

Sponsor
University of Lorraine (Other)
Overall Status
Completed
CT.gov ID
NCT05858658
Collaborator
(none)
9
1
5.3
1.7

Study Details

Study Description

Brief Summary

The goal of this retrospective study is to analyse the outcomes of Robot-Assisted Pyeloplasty in participants younger than 5 years old:

  • indication criteria

  • clinical symptoms

  • operating time

  • length of stay

  • complications

  • follow-up

Condition or Disease Intervention/Treatment Phase
  • Other: Robot-Assisted Pyeloplasty

Detailed Description

Outcomes of Robot-Assisted Pyeloplasty in participants younger than 5 years old and comparison with the outcomes in the literature.

Study Design

Study Type:
Observational
Actual Enrollment :
9 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Robot-Assisted Laparoscopic Pyeloplasty in Children Younger Than 5 Years Old: a Monocentric Retrospective Study
Actual Study Start Date :
Nov 1, 2022
Actual Primary Completion Date :
Dec 31, 2022
Actual Study Completion Date :
Apr 10, 2023

Outcome Measures

Primary Outcome Measures

  1. Presence of ureterohydronephrosis [Before surgery]

    Ureterohydronephrosis represents the augmentation of the diameter of the ureter (more than 10 millimeters) and the renal pelvis (more than 30 millimeters), which can be measured on imaging such as abdominal ultrasound, CT scan, or MRI. Whenever the ureter and the renal pelvis meet these criteria on preoperative imaging, the patient will be labeled as having ureterohydronephrosis.

  2. Presence of abdominal pain [Before surgery]

    Flank pain (pain in the upper abdomen or back)

  3. Presence of urinary calculi [Before surgery]

    Urinary calculi can be diagnosed on an abdominal X-Ray, an abdominal Ultrasound or an abdominal CT scan

  4. Presence of abnormal nuclear renal scans [Before surgery]

    Nuclear renal scans are abnormal when there is a difference of filtration of more than 40% between the kidneys

  5. Presence of urinary tract infection [Before surgery]

    Urinary tract infection associated with ureteropelvic junction

Secondary Outcome Measures

  1. Postoperative pain [After surgery and before discharge home, up to 20 days]

    Mean Digital Pain scale

  2. Postoperative complications [Through study completion, an average of 2 years]

    Pyelonephritis

  3. Operation time [During surgery]

    anesthetic and operating time

  4. hospitalization length [From admission to discharge home, up to 20 days]

    hospitalization length

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 5 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patients younger than 5 years old, who underwent primary robotic pyeloplasty, was launched between January 2014 and December 2022
Exclusion Criteria:
  • Patients older than 5 years old, who underwent primary robotic pyeloplasty, was launched between January 2014 and December 2022

Contacts and Locations

Locations

Site City State Country Postal Code
1 ULorraine Vandœuvre-lès-Nancy Grand-Est France 54500

Sponsors and Collaborators

  • University of Lorraine

Investigators

  • Principal Investigator: Christelle Destinval, MD, University of Lorraine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr Christelle DESTINVAL, Principal Investigator, University of Lorraine
ClinicalTrials.gov Identifier:
NCT05858658
Other Study ID Numbers:
  • ULoripyel
  • 2023PI007
First Posted:
May 15, 2023
Last Update Posted:
May 16, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr Christelle DESTINVAL, Principal Investigator, University of Lorraine

Study Results

No Results Posted as of May 16, 2023